{
  "trial_id": "NCT01663012",
  "trial_group": "cancer",
  "generated-by-gpt4-omni-zs": {
    "gen-response": "Age, sex, Karnofsky Performance Score (KPS), prior treatments (radiation therapy, temozolomide, bevacizumab), time since last chemotherapy, time since last bevacizumab administration, life expectancy, absolute neutrophil count (ANC), hemoglobin (Hgb) level, platelet count, bilirubin level, alanine aminotransferase (ALT) level, aspartate aminotransferase (AST) level, alkaline phosphatase (AP) level, serum creatinine level, creatinine clearance, pregnancy status (for women of childbearing potential).",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "sex"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Male",
        "Ethnicity (NIH/OMB)",
        "Race (NIH/OMB)",
        "Region of Enrollment"
      ],
      "remaining_candidate_features": [
        "Karnofsky Performance Score (KPS)",
        "prior treatments (radiation therapy, temozolomide, bevacizumab)",
        "time since last chemotherapy",
        "time since last bevacizumab administration",
        "life expectancy",
        "absolute neutrophil count (ANC)",
        "hemoglobin (Hgb) level",
        "platelet count",
        "bilirubin level",
        "alanine aminotransferase (ALT) level",
        "aspartate aminotransferase (AST) level",
        "alkaline phosphatase (AP) level",
        "serum creatinine level",
        "creatinine clearance",
        "pregnancy status (for women of childbearing potential)"
      ]
    }
  },
  "generated-by-gpt4-omni-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Karnofsky Performance Score (KPS), Prior treatment with bevacizumab, Time since last chemotherapy, Time since last bevacizumab treatment, Absolute neutrophil count (ANC), Hemoglobin (Hgb), Platelet count, Bilirubin, Alanine aminotransferase (ALT), Aspartate aminotransferase (AST), Alkaline phosphatase (AP), Serum creatinine, Life expectancy,",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Race (NIH/OMB)",
          "Race/Ethnicity"
        ],
        [
          "Region of Enrollment",
          "Region of Enrollment"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Ethnicity (NIH/OMB)"
      ],
      "remaining_candidate_features": [
        "Karnofsky Performance Score (KPS)",
        "Prior treatment with bevacizumab",
        "Time since last chemotherapy",
        "Time since last bevacizumab treatment",
        "Absolute neutrophil count (ANC)",
        "Hemoglobin (Hgb)",
        "Platelet count",
        "Bilirubin",
        "Alanine aminotransferase (ALT)",
        "Aspartate aminotransferase (AST)",
        "Alkaline phosphatase (AP)",
        "Serum creatinine",
        "Life expectancy"
      ]
    }
  },
  "generated-by-llama3-70b-in-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Karnofsky Performance Score, Histological diagnosis, Prior bevacizumab treatment, Prior chemotherapy treatment, Prior radiation therapy, Time from initial diagnosis to recurrence, Time from last bevacizumab treatment to recurrence, Baseline Eastern Cooperative Oncology Group (ECOG) performance status, Baseline Neurological Function Score, Baseline Quality of Life Score.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Race (NIH/OMB)",
          "Race/Ethnicity"
        ],
        [
          "Region of Enrollment",
          "Region of Enrollment"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Ethnicity (NIH/OMB)"
      ],
      "remaining_candidate_features": [
        "Karnofsky Performance Score",
        "Histological diagnosis",
        "Prior bevacizumab treatment",
        "Prior chemotherapy treatment",
        "Prior radiation therapy",
        "Time from initial diagnosis to recurrence",
        "Time from last bevacizumab treatment to recurrence",
        "Baseline Eastern Cooperative Oncology Group (ECOG) performance status",
        "Baseline Neurological Function Score",
        "Baseline Quality of Life Score"
      ]
    }
  },
  "generated-by-llama3-70b-in-zs": {
    "gen-response": "Age, sex, Karnofsky Performance Score (KPS), histological diagnosis (anaplastic astrocytoma, anaplastic oligodendroglioma, glioblastoma), prior treatment with bevacizumab, time from initial diagnosis to recurrence, time from last bevacizumab treatment to recurrence, prior radiation therapy, prior chemotherapy, Eastern Cooperative Oncology Group (ECOG) performance status, serum creatinine, bilirubin, alanine aminotransferase (ALT), aspartate aminotransferase (AST), alkaline phosphatase (AP), absolute neutrophil count (ANC), hemoglobin (Hgb), platelet count.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "sex"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Male",
        "Ethnicity (NIH/OMB)",
        "Race (NIH/OMB)",
        "Region of Enrollment"
      ],
      "remaining_candidate_features": [
        "Karnofsky Performance Score (KPS)",
        "histological diagnosis (anaplastic astrocytoma, anaplastic oligodendroglioma, glioblastoma)",
        "prior treatment with bevacizumab",
        "time from initial diagnosis to recurrence",
        "time from last bevacizumab treatment to recurrence",
        "prior radiation therapy",
        "prior chemotherapy",
        "Eastern Cooperative Oncology Group (ECOG) performance status",
        "serum creatinine",
        "bilirubin",
        "alanine aminotransferase (ALT)",
        "aspartate aminotransferase (AST)",
        "alkaline phosphatase (AP)",
        "absolute neutrophil count (ANC)",
        "hemoglobin (Hgb)",
        "platelet count"
      ]
    }
  }
}